Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Cotrimoxazole in HIV- and HAART-exposed Infants in Botswana

NCT01086878 is registered in ClinicalTrials.gov with Harvard School of Public Health (HSPH) as lead sponsor.

NCT NCT01086878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01086878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Cotrimoxazole in HIV- and HAART-exposed Infants in Botswana
Lead sponsor
Harvard School of Public Health (HSPH)
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2009
Completion date
October 31, 2010
Enrollment
222 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acquired immunodeficiency syndrome, anemia, hiv infections, infant, newborn, neutropenia